Showing 881 - 900 results of 115,651 for search '(( a non decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.56s Refine Results
  1. 881
  2. 882
  3. 883
  4. 884
  5. 885
  6. 886
  7. 887

    Table2_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.docx by Peng Cao (107508)

    Published 2022
    “…<p>The purposes of this study were to identify physiological and genetic factors that contributed to variability of pemetrexed (PEM) exposure and to optimize the dosing regimens for Chinese non-small cell lung carcinoma patients. A prospective population pharmacokinetics (PPK) research was performed in this population. …”
  8. 888

    Table1_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.xlsx by Peng Cao (107508)

    Published 2022
    “…<p>The purposes of this study were to identify physiological and genetic factors that contributed to variability of pemetrexed (PEM) exposure and to optimize the dosing regimens for Chinese non-small cell lung carcinoma patients. A prospective population pharmacokinetics (PPK) research was performed in this population. …”
  9. 889

    Table1_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.xlsx by Peng Cao (107508)

    Published 2022
    “…<p>The purposes of this study were to identify physiological and genetic factors that contributed to variability of pemetrexed (PEM) exposure and to optimize the dosing regimens for Chinese non-small cell lung carcinoma patients. A prospective population pharmacokinetics (PPK) research was performed in this population. …”
  10. 890

    Table2_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.docx by Peng Cao (107508)

    Published 2022
    “…<p>The purposes of this study were to identify physiological and genetic factors that contributed to variability of pemetrexed (PEM) exposure and to optimize the dosing regimens for Chinese non-small cell lung carcinoma patients. A prospective population pharmacokinetics (PPK) research was performed in this population. …”
  11. 891

    Decreased dissemination and parasite load after adoptive transfer of <i>Toxoplasma</i>-infected DC treated with GABAergic inhibitors. by Jonas M. Fuks (113543)

    Published 2012
    “…Data are from one set of mice and representative of two independent experiments with three to five mice per group. (<b>B</b>) Total photon emission analysis from individual mice on days 1–5 post inoculation showed a decrease in parasite tissue burden in mice inoculated with GAD and GAT4 inhibitor-treated DC infected with <i>T. gondii</i> when compared with burdens from mice inoculated with untreated DC infected with <i>T. gondii</i>. …”
  12. 892
  13. 893

    The surface area of breast tumors in PyMT transgenic mice was decreased after three weeks of voluntary wheel running. by Jorming Goh (490491)

    Published 2013
    “…<p>Values are means ± standard deviation (N = 12 per group). A. Size of all breast tumors in runners was significantly decreased compared to non-runners (p = 0.01). …”
  14. 894
  15. 895
  16. 896

    DataSheet_1_Decreasing Shortest Path Length of the Sensorimotor Network Induces Frontal Glioma-Related Epilepsy.pdf by Shengyu Fang (9134117)

    Published 2022
    “…Moreover, the shortest path length decrease was found in the GRE group compared with the non-GRE group [p = 0.0292 (left glioma) and p = 0.0129 (right glioma)].…”
  17. 897
  18. 898
  19. 899
  20. 900